血清DNA-P RIA对肺癌的诊断意义  

The Diagnostic Value of Serum DNA-polymerase Combined RIA in Patients with Lung Cancer

作　　者：黄卫东[1] 杨云梅[2] 杨滔波[3] 龚惠萍 郑晖 王林[3] 

机构地区：[1]浙江医科大学附属邵逸夫医院,杭州310016 [2]浙江医科大学附属第一医院,杭州310003 [3]浙江绍兴第二医院,绍兴312000 [4]杭州市运河船舶修造厂医务室,杭州310015

出　　处：《浙江肿瘤》1995年第1期38-39,共2页

摘　　要：血清DNA－PRIA是一种新的广谱的恶性肿瘤的标志物，对诊断恶性肿瘤具有广谱性和诊断符合率高的特点，本文测定肺癌病人血清58例，其阳性率占82．76％（48例），检测肺部良性疾病病人血清160例作对照，阳性率4．38％（7例），（p＜0．01），又测定100例正常人血清，阳性率为0（P＜0．01），提示血清DNA－PRLA对肺癌的诊断具有重要的临床意义。Serum DNA- polymerase (DNA-P)is regarded as a new broad-spectrum tumor marker. It is very important clinical siguifi-cance for the diagnosis of malignant tumor. In Fifty-eight Patients with examining lung cancer, 82. 76 % (48 cases) were DNA-P RIA POsi-tive. In 160 patients of lung benign disease 4.38% (7 cases)were DNA-P Rm opitive (p<0. 01). In 1 00 normal human none was positive (p<0.01). Serum DNA-P RLA has important Value in the diagnosis of lung cancer.

关 键 词：DNA-P 肺癌 放射免疫法 诊断 

分 类 号：R734.204[医药卫生—肿瘤]